Orgenesis Statistics
Share Statistics
Orgenesis has 5.17M shares outstanding. The number of shares has increased by -85.03% in one year.
| Shares Outstanding | 5.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -89.9% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.19M |
| Failed to Deliver (FTD) Shares | 144 |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 56.25K, so 1.18% of the outstanding shares have been sold short.
| Short Interest | 56.25K |
| Short % of Shares Out | 1.18% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 2.39 |
Valuation Ratios
The PE ratio is -2.62 and the forward PE ratio is 1.97.
| PE Ratio | -2.62 |
| Forward PE | 1.97 |
| PS Ratio | 273.66 |
| Forward PS | null |
| PB Ratio | -6.91 |
| P/FCF Ratio | -8.57 |
| PEG Ratio | n/a |
Enterprise Valuation
Orgenesis Inc. has an Enterprise Value (EV) of 36.31M.
| EV / Earnings | -0.66 |
| EV / Sales | 68.51 |
| EV / EBITDA | -0.6 |
| EV / EBIT | -0.68 |
| EV / FCF | -2.14 |
Financial Position
The company has a current ratio of 0.25, with a Debt / Equity ratio of -1.08.
| Current Ratio | 0.25 |
| Quick Ratio | 0.25 |
| Debt / Equity | -1.08 |
| Total Debt / Capitalization | 1.38K |
| Cash Flow / Debt | -0.66 |
| Interest Coverage | -24.75 |
Financial Efficiency
Return on equity (ROE) is 2.64% and return on capital (ROIC) is -3298.51%.
| Return on Equity (ROE) | 2.64% |
| Return on Assets (ROA) | -3.8% |
| Return on Capital (ROIC) | -3298.51% |
| Revenue Per Employee | 3.63K |
| Profits Per Employee | -379.18K |
| Employee Count | 146 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 183.97 |
Taxes
| Income Tax | 473.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -58.06% in the last 52 weeks. The beta is 1.32, so Orgenesis 's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -58.06% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 45.96 |
| Average Volume (20 Days) | 30.75K |
Income Statement
In the last 12 months, Orgenesis had revenue of 530.00K and earned -55.36M in profits. Earnings per share was -1.91.
| Revenue | 530.00K |
| Gross Profit | -5.72M |
| Operating Income | -53.64M |
| Net Income | -55.36M |
| EBITDA | -60.72M |
| EBIT | -53.64M |
| Earnings Per Share (EPS) | -1.91 |
Balance Sheet
The company has 837.00K in cash and 22.62M in debt, giving a net cash position of -21.78M.
| Cash & Cash Equivalents | 837.00K |
| Total Debt | 22.62M |
| Net Cash | -21.78M |
| Retained Earnings | -176.62M |
| Total Assets | 29.69M |
| Working Capital | -33.53M |
Cash Flow
In the last 12 months, operating cash flow was -14.84M and capital expenditures -2.10M, giving a free cash flow of -16.93M.
| Operating Cash Flow | -14.84M |
| Capital Expenditures | -2.10M |
| Free Cash Flow | -16.93M |
| FCF Per Share | -0.58 |
Margins
Gross margin is -1.08K%, with operating and profit margins of -10.12K% and -10.45K%.
| Gross Margin | -1.08K% |
| Operating Margin | -10.12K% |
| Pretax Margin | -12.16K% |
| Profit Margin | -10.45K% |
| EBITDA Margin | -11.46K% |
| EBIT Margin | -10.12K% |
| FCF Margin | -3.19K% |
Dividends & Yields
ORGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -126.49% |
| FCF Yield | -216.93% |
Analyst Forecast
Currently there are no analyst rating for ORGS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 25, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Sep 25, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -14.91 |
| Piotroski F-Score | 2 |